Aebi Schmidt (AEBI) Q2 2026 Earnings Call Transcript

Aebi Schmidt reported Q2 2026 net sales of $496M (+9.4% organic) and adjusted EBITDA of $42.1M (+22% YoY), lifting adjusted EBITDA margin 19 bps to 8.5%, while net income improved by $18M to $10.5M. Order intake rose 16% to $516M and backlog grew 20% YoY to ~$1.279B, supporting profitability through continued backlog conversion despite temporary gross-margin pressure from supply-chain disruption and tariff/geopolitical-linked cost inflation. The company reaffirmed FY2026 guidance (sales $1.95B–$2.15B; adjusted EBITDA $175M–$195M) and guided leverage to 2x or slightly above by year-end 2026 after a planned period of higher inventory/supply-chain investment.

Analysis

The key mechanism here is not top-line growth; it is backlog conversion plus a delayed pricing catch-up. That favors equity holders over the next 2-4 quarters because reported revenue should stay sticky while the margin bridge improves as old, lower-priced orders roll off, but it also means near-term gross margin can look softer than the street wants. The bigger winner is AEBI’s aftermarket/service ecosystem: expanding field service and in-house body production should lift mix and reduce dependence on lower-margin chassis work.

Competitive dynamics look better than the headline implies. The Ford/Blue Bird chassis transition likely reduces supply uncertainty for the whole walk-in van market, which helps AEBI more than it hurts because the company appears to be deepening supply relationships rather than fighting for constrained slots. The second-order loser is any upfitter that lacks scale in sourcing, has weaker integration, or is more exposed to tariff-driven input inflation; if AEBI can keep converting volume while smaller rivals absorb cost shocks, share gains can persist into 2027.

The main risk is timing: management is effectively saying the margin payoff arrives after the backlog clears, so the stock can stall if investors expect an immediate step-function. The frame contract is strategically useful but not a near-term revenue driver, so the market may be overvaluing the visibility number versus actual 2026 cash conversion. Contrarian view: the move may be underdone on a 6-12 month view because deleveraging plus synergy realization can support multiple expansion, but overdone for the next few weeks if consensus is already pricing a clean gross-margin rebound. A miss on material costs, or leverage failing to trend toward 2x by early 2027, would falsify the thesis.

Key Decisions for Investors

• Long AEBI common on a 3-6 month horizon, ideally on any post-earnings fade; thesis is delayed pricing power plus synergy realization, with upside if 2026 EBITDA guidance proves conservative.
• Do not chase near-term momentum with call options: the margin inflection is likely 2-3 quarters out, so equity offers better risk/reward than paying up for short-dated optionality.
• Use AEBI as a relative-long versus lower-quality specialty vehicle or body-builder exposure if available; the cleaner deleveraging path and stronger backlog conversion should deserve a premium.
• Watch for confirmation in the next two quarters: gross margin expansion, working-capital ratio continuing toward 20%-ish, and leverage moving toward 2x; if those stall, reduce.
• If the stock rerates sharply on the print, take partial profits into strength and wait for evidence that price increases are actually flowing through, since backlog delays can mask a later margin reset.